KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

acute kidney injury, severe gastrointestinal reactions, hypersensitivity, acute gallbladder disease, and pulmonary aspiration during anesthesia.

Acute kidney injury was defined according to the ... Thirty (30%) had co-morbid chronic kidney disease or end-stage renal disease. The median time of renal recovery was 39.6 days (range, 1 ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

Acute renal failure occurs rapidly, causing generalized symptoms, such as nausea and confusion. It is a serious condition, but it can be treated. With proper treatment, most people can survive an ...

End-stage renal disease (ESRD ... patients with CKD is associated with lower rate of acute healthcare utilization, all-cause death and kidney events compared to DPP4i.

Mr Steve Obinna Ugboaja, 46, from Akpaa Mbato Community in Obingwa Local Government Area of Abia State, who needs N30M million for a kidney transplant, has made a passionate appeal to public-spirited ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

The elderly represent a continuously growing fraction of the end-stage renal disease (ESRD ... metabolic syndrome and previous acute kidney injury, could potentially affect age-related decline ...

Pathologist Dr Margot Bolster said Breeda O’Donoghue's death should be referred to the Health Products Regulatory Authority ...

Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an ...